News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Joins With IMS Health (RX) to Evaluate Drug Impacts


1/11/2012 7:04:42 AM

U.K. drug maker AstraZeneca PLC (AZN) has struck a deal with a health-care consultancy to gain further information on how its drugs are faring on the market and in hospitals, reflecting a growing need for pharmaceutical companies to prove the cost-efficiency of their products to cash-strapped governments. The U.K.'s No. 2 drug maker said the three-year venture with U.S.-based IMS Health will give it access to electronic health records, which include clinical outcome, economic and treatment pattern data. The companies will also jointly develop a customized research and data analysis platform. No financial terms were disclosed. AstraZeneca has a similar relationship in the U.S. with HealthCore, the health outcomes research subsidiary of health insurer WellPoint Inc. (WLP).



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES